BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31180050)

  • 21. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer.
    Zhao R; Zhang Y; Zhang X; Yang Y; Zheng X; Li X; Liu Y; Zhang Y
    Mol Cancer; 2018 Feb; 17(1):68. PubMed ID: 29486794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
    Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
    Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation.
    Han S; Park K; Kim HY; Lee MS; Kim HJ; Kim YD
    Breast Cancer Res Treat; 1999 May; 55(2):161-7. PubMed ID: 10481943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
    Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
    Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
    Baxter DE; Kim B; Hanby AM; Verghese ET; Sims AH; Hughes TA
    Clin Breast Cancer; 2018 Dec; 18(6):481-488. PubMed ID: 30055962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tumor exosome-derived Lnc RNA HOTAIR on the growth and metastasis of gastric cancer.
    Chen P; Liu Z; Xiao H; Yang X; Li T; Huang W; Zhou H
    Clin Transl Oncol; 2023 Dec; 25(12):3447-3459. PubMed ID: 37199906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer.
    Xue X; Yang YA; Zhang A; Fong KW; Kim J; Song B; Li S; Zhao JC; Yu J
    Oncogene; 2016 May; 35(21):2746-55. PubMed ID: 26364613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy.
    Litviakov NV; Cherdyntseva NV; Tsyganov MM; Slonimskaya EM; Ibragimova MK; Kazantseva PV; Kzhyshkowska J; Choinzonov EL
    Oncotarget; 2016 Feb; 7(7):7829-41. PubMed ID: 26799285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.
    Mazouni C; Hall A; Broglio K; Fritsche H; Andre F; Esteva FJ; Hortobagyi GN; Buzdar AU; Pusztai L; Cristofanilli M
    Cancer; 2007 Feb; 109(3):496-501. PubMed ID: 17149760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should women with early breast cancer under 40 years of age have a routine 21-gene recurrence score testing: A SEER database study.
    Liu KH; Zhang L; Chen JX; Lian CL; Wang J; He ZY; Wu SG
    Breast; 2020 Feb; 49():233-241. PubMed ID: 31918322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
    Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
    Li S; Zhang M; Zhang H; Hu K; Cai C; Wang J; Shi L; Ma P; Xu Y; Zheng P
    Clin Chim Acta; 2020 Feb; 501():252-257. PubMed ID: 31730812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancer With Serum VEGF as Primary Endpoint: The NEOZOL Study.
    Lelièvre L; Clézardin P; Magaud L; Roche L; Tubiana-Mathieu N; Tigaud JD; Topart D; Raban N; Mouret-Reynier MA; Mathevet P
    Clin Breast Cancer; 2018 Dec; 18(6):e1311-e1321. PubMed ID: 30098917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle.
    Yan ZC; He L; Qiu JH; Deng WT; Lu JR; Yuan Z; Liu DJ; Zheng RQ; Jiang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6640-6649. PubMed ID: 30402836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
    Meattini I; Livi L; Saieva C; Franceschini D; Scotti V; Mangoni M; Loi M; Di Brina L; Zei G; Bonomo P; Greto D; Gelain E; Nori J; Sanchez LJ; Orzalesi L; Bianchi S; Biti G
    Clin Breast Cancer; 2013 Aug; 13(4):247-53. PubMed ID: 23684167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
    Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
    Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
    Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
    Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
    Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
    Wang Y; Wang H; Song T; Zou Y; Jiang J; Fang L; Li P
    Mol Med Rep; 2015 Aug; 12(2):2211-6. PubMed ID: 25824616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
    Na-Er A; Xu YY; Liu YH; Gan YJ
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.